Cognitive
9
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Effectiveness of a Dual Program for Improving Sleep in Older Adults.
The Acute Effects of Onnit Alpha Brain on Cognition and Mood States
Non-Invasive Detection and Preservation of Neurocognitive Signals in the Peri-Death Period Using Brain-Computer Interface and Artificial Intelligence
Multisensory Environment-Based Occupational Therapy for Alzheimer's Patients
To Evaluate the Efficacy of Lutemax 2020 on Vision and Cognitive Performance in Health Children.
Multimodal Brain Function in Migraine Patients With Patent Foramen Ovale
A Predictive Model for Postoperative Delirium in Kidney Transplant Patients
Cognitive Health Awareness Program in Surgical Patients
Acute Nerve Stimulation For Enhancing Human and Cognitive Performance